February 19-22 event in Sarasota, Florida features hands-on ultrasound training and sessions on emerging biologics, ...

Real-world evidence (RWE) empowers payers and providers to make more informed, cost-effective treatment. Read more here: ...

Panelists discuss how clinical trial outcomes like CROWN and eXalt3 reflect real-world patient experiences and how these collective data have changed perspectives on frontline therapies for ALK+ ...

Margaret Krackeler, MD, discusses real-world data supporting the switch from ibrutinib to zanubrutinib for chronic lymphocytic leukemia.

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

Vera Igbokwe, a finalist for the Educator of the Year, centers teamwork, real-world healthcare skills, and encouragement in her health science classes.

Researchers conducted the UP-TAINED study to assess the effectiveness and safety of upadacitinib for over 2 years, with patients with moderate to severe AD receiving either 15 mg or 30 mg once daily.

Real-world, 12-month results demonstrated efficacy, safety and durability for faricimab as a treatment for retinal vein occlusion, according to a speaker at Retina 2026.In light of faricimab’s ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S. Although biomarker testing in early-stage non-small cell ...